CSIMarket Company Name, Ticker, Customers, else..


Foamix Pharmaceuticals Ltd   (FOMX)
Other Ticker:  
 

Foamix Pharmaceuticals Ltd

FOMX's Fundamental analysis



Foamix Pharmaceuticals Ltd 's sales fell by -84.3 % in IV. Quarter 2019 from the same quarter a year ago. Ranking at No. 3740

Legal Cannabis industry recorded deterioration of revenues by -22.3 %

Foamix Pharmaceuticals Ltd 's net income grew by 168.65 % in IV. Quarter 2019 year on year, above company average,

• More on FOMX's Growth


Foamix Pharmaceuticals Ltd
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Company is currently trading with Price to Cash flow multiple of 11.72 in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months.
Company
1.84
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 434.58.
Legal Cannabis industry's Price to Sales ratio is at 6.59.


• More on FOMX's Valuation
 
 Total Debt (Millions $) 33
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 6,515
 Net Income/Employee (TTM) $ 1,399,676
 Receivable Turnover (TTM) 0.34
 Tangible Book Value (Per Share $) 0.27

Foamix Pharmaceuticals Ltd
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Company is currently trading with Price to Cash flow multiple of 11.72 in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months.
Company
1.84
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 434.58.
Legal Cannabis industry's Price to Sales ratio is at 6.59.

Foamix Pharmaceuticals Ltd Price to Book Ratio is at 10.95 lower than Indusry Avg. of 23.47. and higher than S&P 500 Avg. of -0.01

• More on FOMX's Valuation

•  Market Capitalization (Millions $) 193
•  Shares Outstanding (Millions) 64
•  Employees 68
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 95
•  Cash Flow (TTM) (Millions $) 16
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) 33
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 6,515
•  Net Income/Employee(TTM) $ 1,399,676
•  Receivable Turnover Ratio (TTM) 0.34
•  Tangible Book Value (Per Share $) 0.27

•  Market Capitalization (Millions $) 193
•  Shares Outstanding (Millions) 64
•  Employees 68
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 95
•  Cash Flow (TTM) (Millions $) 16
•  Capital Exp. (TTM) (Millions $) -1


    FOMX's Profitability Comparisons
Foamix Pharmaceuticals Ltd